Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Murthy S et al. | Ischemia/reperfusion injury in the rat colon. | 1997 | Inflammation | pmid:9187961 |
Bräutigam R et al. | Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia. | 1997 | Atherosclerosis | pmid:9180250 |
Vila V et al. | Fibrinopeptide A release from intraplatelet fibrinogen is related to thrombin platelet activation. | 1997 | Thromb. Res. | pmid:9175247 |
Barbieri B et al. | p-Aminobenzoic acid, but not its metabolite p-acetamidobenzoic acid, inhibits thrombin induced thromboxane formation in human platelets in a non NSAID like manner. | 1997 | Thromb. Res. | pmid:9175234 |
Oguogho A et al. | Chloroquine minimizes sampling artefacts for radioimmunological determination of thromboxane B2 in plasma. | 1997 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9175176 |
Klosterhalfen B et al. | The influence of heat shock protein 70 induction on hemodynamic variables in a porcine model of recurrent endotoxemia. | 1997 | Shock | pmid:9165671 |
Low-dose aspirin in polycythaemia vera: a pilot study. Gruppo Italiano Studio Policitemia (GISP). | 1997 | Br. J. Haematol. | pmid:9163613 | |
Shimada Y et al. | Role of platelets in myocardial ischemia-reperfusion injury in dogs. | 1997 | Jpn. Circ. J. | pmid:9152773 |
Closa D et al. | Prostanoids and free radicals in Cl4C-induced hepatotoxicity in rats: effect of astilbin. | 1997 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9150380 |
Sinzinger H et al. | PGE1-induced arterial thromboresistance is a vascular property as identified by cross-perfusion technique. | 1997 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9150379 |
Zhang T et al. | Effects of the incubation of long-chain polyunsaturated fatty acids on platelet lipids and thromboxane release. | 1997 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9150370 |
Kraft M et al. | The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma. | 1997 | Chest | pmid:9149578 |
Roberts LJ et al. | Metabolism of thromboxane B2 in man. Identification of the major urinary metabolite. | 1977 | J. Biol. Chem. | pmid:914816 |
Bishop-Bailey D et al. | Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. | 1997 | Br. J. Pharmacol. | pmid:9146896 |
Riendeau D et al. | Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. | 1997 | Br. J. Pharmacol. | pmid:9146894 |
Henrion D et al. | Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. | 1997 | Br. J. Pharmacol. | pmid:9146891 |
Todd MK et al. | Comparison of methods for evaluating exercise-induced changes in thromboxane B2 and beta-thromboglobulin. | 1997 | Med Sci Sports Exerc | pmid:9140910 |
Olson KR et al. | Cardiovascular effects of homologous bradykinin in rainbow trout. | 1997 | Am. J. Physiol. | pmid:9140009 |
Oelkers R et al. | Disposition and effects of flurbiprofen enantiomers in human serum and blister fluid. | 1997 | Br J Clin Pharmacol | pmid:9131946 |
He CF et al. | Postural vasoregulation and mediators of reperfusion injury in venous ulceration. | 1997 | J. Vasc. Surg. | pmid:9129619 |